← SynDRA
EXALAMIDE
SynDRA canonical compound SYN0025207 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Mechanism of action | membrane permeability inhibitor |
|---|
Mechanisms of action (all sources)
- membrane permeability inhibitor
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- HTR2B
- HDAC6
- ESR1
- OPRK1
- NR1I2
- ADORA1
- NR3C1
- HTR2C
- HTR3A
- KCNH2
- LMNA
- MAOA
- MAPT
- MC3R
- MLNR
- NPY1R
- OPRD1
- HTR1A
- OPRM1
- PDE3A
- PDE4D
- PGR
- PTGS2
- SLC29A1
- SLC6A2
- SLC6A3
- SLC6A4
- SLCO1B3
- TBXA2R
- TDP1
- HTR2A
- HRH2
- HRH3
- CCKBR
- ADORA3
- ADRA1A
- ADRA2A
- ADRA2B
- ADRA2C
- ADRB1
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- 5HT2A
- AHR
- ANDR
- CP1A2
- CP2C9
- CP2CJ
- CP3A4
- CP3A7
- ESRRA
- GNRHR
- NF2L2
- PRGR
- RARA
Cross-references
Synonyms
- 2-n-Hexyloxybenzamide
- hyperan
- Exalamida
- O-(hexyloxy)benzamide
- NSC-758449
- 2-(Hexyloxy)benzamide
- Hyperan
- 2-hexoxybenzamide
- o-(Hexyloxy)benzamide
- o-Hexyloxybenzamide
- 2-Hexyloxybenzamide
- Exalamidum
- 7JEC65JCG2
- NSC 758449
- ortho-hexyloxybenzamide
- DTXCID7025899
- CHEBI:31585
- RefChem:921404
- Benzamide, 2-(hexyloxy)-
- NCGC00095049-01
- Exalamide [INN:JAN]
- Exalamidum [INN-Latin]
- Exalamida [INN-Spanish]
- CAS-53370-90-4
- H.P. 216
- EINECS 258-504-3
- UNII-7JEC65JCG2
- BRN 2645003
- BENZAMIDE, o-HEXYLOXY-
- Spectrum_001729
- Exalamide (JAN/INN)
- EXALAMIDE [INN]
- EXALAMIDE [JAN]
- EXALAMIDE [MI]
- Spectrum2_000869
- Spectrum5_001095
- EXALAMIDE [WHO-DD]
- KBioSS_002209
Look up EXALAMIDE in the interactive SynDRA portal →